Case report
Open access
Sep 2026
[Sacituzumab govitecan in ER+/HER2- breast cancer: a necessary treatment option for patients who have undergone multiple prior treatments.]
A 65-years-old woman who underwent right mastectomy in 2010 for invasive ductal carcinoma of the breast gave this woman a chance, in a scenario poor in exciting options, to use SG in luminal breast cancer patients.
L. Scortichini, N. Battelli
· Recenti progressi in medicin... · 0 citations